ACTIVE

MegaGen BeLux

Financial year 2025 · Closed on 31/12/2025

Net result-33,1 k €-486,3 %over 1 year
Gross margin25,8 k €-76,7 %over 1 year
Equity-24,9 k €-404,8 %over 1 year

Identity

Source · BCE/KBO

MegaGen BeLux is a Private limited company incorporated in 2022. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Bruxelles.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0793.466.136
Incorporation
10/11/2022
Legal form
Private limited company
Registered office
Cantersteen 47
1000 Bruxelles · BruxellesSee on map
Contributed capital
10 000,00 €
Latest accounts
31/12/2025
Joint committees (1)
  • 200
Signals
Good liquidityHealthy social debts

Financials

Source · NBB, 3 filings

Trend over 3 financial years

202520242023
Income statement
Gross margin25,8 k €110,8 k €116,6 k €
EBITDA-36,4 k €11,2 k €1,8 k €
Operating result-36,4 k €11,2 k €1,8 k €
Net result-33,1 k €8,6 k €-10,4 k €
Balance sheet
Equity-24,9 k €8,2 k €-391,9 €
Total assets100,2 k €66,1 k €28,8 k €
Cash1,7 k €197,1 €174,8 €
Debts75 k €57,7 k €29,2 k €

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 1 ended

Active mandates

MegaGen Benelux BV

Director · since 10 novembre 2022

Represented by Eduard VERSCHUUREN

Active

Ended mandates

MegaGen Benelux B.V.

Director · since 10 novembre 2022

Represented by Verschuuren EDUARD

Ended

Other companies at this address

Cantersteen 47 1000 Bruxelles
CompanyCBE no.
13 ANALYTICS● Active
0793.625.987
0506.804.115
0778.940.781
1034.146.494
1007.736.067
1010.584.897
Ahead Digital● Active
0867.212.266
AlexandriteF● Active
0804.051.905
0780.685.989
0696.869.477
AMBOS Law● Active
0550.946.241
AMCAHub● Active
1025.495.282
0409.404.336
0800.049.664
0742.927.255
0733.604.961
Aricoma Systems● Active
0767.591.979
Arts 28● Active
1025.504.487
0453.963.760
0407.622.902

Full financial information

Source · NBB
202520242023
Type of accountAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/11/2022
Closing of the financial year31/12/202531/12/202431/12/2023
Length of the financial year12 months12 months14 months
Filing date31/08/202622/07/202523/07/2024
General meeting26/06/202627/06/202528/06/2024
Currency of the financial yearEUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 3 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202526/06/202631/08/2026DutchPDF
Abridged model31/12/202427/06/202522/07/2025DutchPDF
Abridged model31/12/202328/06/202423/07/2024DutchPDF

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 1 ended

Active mandates

MegaGen Benelux BV

Director · since 10 novembre 2022

Represented by Eduard VERSCHUUREN

Active

Ended mandates

MegaGen Benelux B.V.

Director · since 10 novembre 2022

Represented by Verschuuren EDUARD

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Other16/11/2022
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-33,1 k €↓
  2. 2024
    Annual accounts 20248,6 k €↑
  3. 2023
    Annual accounts 2023-10,4 k €
  4. 10/11/2022
    IncorporationPrivate limited company